NCT04518644 2023-04-28
Nilotinib, for Patients With CML-CP or CML-AP
Novartis
No longer available
Clinical Trials
3 trialsNCT04559555 2022-08-09
MAP to Provide Access to Nilotinib, for Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Novartis
No longer available
NCT00302016 2011-08-26
Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
Novartis
No longer available